Bemfivastatin (PPD 10558) hemicalcium is an orally active HMG-CoA Reductase (HMGCR) inhibitor. Bemfivastatin hemicalcium enhances the activity of liver extraction and reduces blood lipid levels. Bemfivastatin hemicalcium can be used for research of metabolic disease, such as hypercholesterolemia[1][2].
Molecular Weight:
607.74
Purity:
98.00
CAS Number:
[805241-64-9]
Formula:
C34H36FN2O6.1/2Ca
Target:
HMG-CoA Reductase (HMGCR)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted